BSE Live
Oct 20, 16:01Prev. Close
48.12
Open Price
48.22
Bid Price (Qty.)
48.37 (1968)
Offer Price (Qty.)
48.62 (190)
NSE Live
Oct 20, 15:59Prev. Close
48.09
Open Price
48.35
Bid Price (Qty.)
48.44 (3383)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Morepen Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 1,803.73 | 1,682.13 | 1,413.95 | 1,541.57 | 1,175.37 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 1,803.73 | 1,682.13 | 1,413.95 | 1,541.57 | 1,175.37 | |
Total Operating Revenues | 1,811.58 | 1,690.43 | 1,417.53 | 1,546.83 | 1,188.06 | |
Other Income | 18.36 | 13.97 | 6.13 | 10.31 | 12.07 | |
Total Revenue | 1,829.94 | 1,704.40 | 1,423.66 | 1,557.13 | 1,200.13 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 999.18 | 883.31 | 781.41 | 797.13 | 617.93 | |
Purchase Of Stock-In Trade | 207.25 | 177.00 | 157.85 | 262.23 | 204.20 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | -47.12 | 2.11 | 16.48 | -10.04 | -41.58 | |
Employee Benefit Expenses | 208.91 | 181.47 | 154.68 | 164.25 | 135.59 | |
Finance Costs | 8.34 | 3.71 | 1.98 | -7.37 | 1.79 | |
Depreciation And Amortisation Expenses | 28.98 | 33.47 | 27.93 | 27.64 | 30.28 | |
Other Expenses | 269.28 | 287.92 | 227.57 | 196.59 | 153.40 | |
Total Expenses | 1,674.83 | 1,568.99 | 1,367.91 | 1,430.43 | 1,101.61 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 155.11 | 135.42 | 55.76 | 126.70 | 98.51 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 155.11 | 135.42 | 55.76 | 126.70 | 98.51 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 32.37 | 39.32 | 16.82 | 25.28 | 1.43 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 4.73 | -0.44 | 0.20 | 2.48 | 0.00 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 37.09 | 38.80 | 17.08 | 25.02 | 1.42 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 118.02 | 96.62 | 38.68 | 101.68 | 97.09 | |
Profit/Loss From Continuing Operations | 118.02 | 96.62 | 38.68 | 101.68 | 97.09 | |
Profit/Loss For The Period | 118.02 | 96.62 | 38.68 | 101.68 | 97.09 | |
Minority Interest | 0.01 | -0.46 | 0.00 | 0.00 | 0.00 | |
Consolidated Profit/Loss After MI And Associates | 118.02 | 96.16 | 38.68 | 101.68 | 97.09 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 2.00 | 2.00 | 1.00 | 2.00 | 2.00 | |
Diluted EPS (Rs.) | 2.00 | 2.00 | 1.00 | 2.00 | 2.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y